BioVaxys and The Ohio State University Progress Pan-Sarbecovirus Vaccine Research Program
- Friday, June 3, 2022, 7:04
- Finance
- Add a comment
Pan-Sarbecovirus Vaccines Identified by WHO as a Critical Need VANCOUVER, BC, June 3, 2022 /PRNewswire/ — BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (“BioVaxys” or “Company”) announced today that The Ohio State University (“Ohio State”), its research collaborator…
About the Author
adminasapcorp has written 41532 stories on this site.